Bill

Bill > SB914


MD SB914

MD SB914
Hospitals - Testing for Fentanyl (The Josh Siems Act)


summary

Introduced
02/15/2023
In Committee
04/07/2023
Crossed Over
03/27/2023
Passed
04/10/2023
Dead
Signed/Enacted/Adopted
05/03/2023

Introduced Session

2023 Regular Session

Bill Summary

AN ACT concerning Hospitals - Overdoses - Testing for Fentanyl (The Josh Siems Act) FOR the purpose of requiring the emergency department of a hospital to conduct a rapid include testing for fentanyl as part of a urine drug test for fentanyl in patients with a known or suspected drug overdose screening; and generally related to fentanyl testing for hospital patients with a known or suspected overdose. BY adding to Article - Health - General Section 19-308.9 Annotated Code of Maryland (2019 Replacement Volume and 2022 Supplement)

AI Summary

This bill, known as the Josh Siems Act, requires hospitals in Maryland to conduct a urine drug screening that includes testing for fentanyl when treating patients with a known or suspected drug overdose. The bill mandates that if the urine drug screening detects fentanyl, the hospital must report the deidentified test results to the Maryland Department of Health through the state-designated health information exchange. The bill provides an exception for hospitals that do not have the necessary chemical analyzer equipment to conduct the fentanyl test. Additionally, the bill does not affect existing laws that provide civil or criminal immunity to individuals who assist others in need of medical attention after using alcohol or drugs.

Committee Categories

Budget and Finance, Government Affairs, Health and Social Services

Sponsors (2)

Last Action

Approved by the Governor - Chapter 324 (on 05/03/2023)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...